The RedShiftBio team has just returned from Colorado where we attended a great workshop on aggregation and immunogenicity. Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding the role of aggregates during immunogenicity of therapeutic protein products is critical, and therefore was the Workshop focus. Our AQS3TMpro is a powerful analyzer for monitoring the onset and presence of aggregation. It is one of the only techniques which can directly monitor the formation of aggregates due to its ability to measure intermolecular beta sheet structures.
To learn more about how the AQS3pro can be used to assess aggregation, visit our applications page.